Mizuho reiterated its bullish stance on biotech Neumora Therapeutics Inc. on Wednesday, and predicted a positive outcome when the company reports data from a late-stage trial of its treatment for ...
Listen to this article Tennessee-based Microporous will invest $1.3 billion to build its battery separator manufacturing facility at the Southern Virginia Megasite at Berry Hill in Pittsylvania County ...
In September, we started enrollment in our Phase 2b study evaluating our COVID-19 oral pill vaccine candidate against ... and diarrhea and sickens approximately 21 million people in the United States ...
IN8bio will present updated clinical trial results from INB-200 in a Plenary Oral Presentation at the Society for Neuro-Oncology (SNO) in November 2024. A poster presentation updating patient data ...